FIELD: medicine, pharmacy. SUBSTANCE: solid medicinal form of the prolonged action releases an active substance continuously for 15 h independently of gastroenteric tract pH value. Composition has core containing metoprolol and shell and consists of a lot of globules (size is 0.25-2 mm) core of that have at least 95 wt.-% metoprolol as salt (solubility in water is 600 mg/ml at 25 C). Active substance is released at velocity 3-7 wt.-%/h. Polymeric shell is applied on each globule. Preferable globule size is 0.35-1.0 mm. Metoprolol salt can be benzoate or sorbate of metoprolol S-enantiomer. Globule content can contain metoprolol salt applied on the insoluble core made of silicon dioxide. Insoluble core made of silicon dioxide can show size 0.1-1.0 mm, preferably 0.15-0.3 mm, and to be coated with metoprolol salt. The formed globules (size is 0.35-1.0 mm) were coated with polymeric shell. Polymeric shell can be made of ethylcellulose or its mixture with hydroxypropylmethylcellulose. Medicinal form can be made as gelatin capsule filled with globules coated with polymeric shell, or as tablet made of the pressed globules with pharmaceutical additions. EFFECT: enhanced quality of medicinal form. 15 cl, 3 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING SOLID DRUG FORM METHOPROLOL HAVING CONTROLLED RELEASING | 0 |
|
SU1760969A3 |
METHOD FOR OBTAINING A MEANS WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE | 0 |
|
SU1706373A3 |
SUSTAINED-ACTION PHARMACEUTICAL COMPOSITION FOR TREATING HEART DISEASES | 2011 |
|
RU2464018C1 |
COMPOSITION FOR PER OS TREATING INFLAMMATORY GASTROENTERIC TRACT DISEASES | 1990 |
|
RU2134104C1 |
SOLID MEDICINAL FORMULA FOR ORAL ADMINISTRATION | 1992 |
|
RU2095054C1 |
PHARMACEUTICAL COMPOSITION CONTAINING CARDIOSELECTIVE BETA-ADRENOBLOCKER | 2001 |
|
RU2190397C1 |
METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
4-FLUORO-2-{[ (4-METHOXY- 2-PYRIDINYL)METHYL]SULFINYL} -1H-BENZI- MIDAZOLE OR ITS PHYSIOLOGICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, AND PHARMACEUTICAL COMPOSITION OF 4-FLUORO -2-MERCAPTO-1H- BENZIMIDAZOLE AND 4-FLUORO -2-{[(4- METHOXY-2-PYRIDINYL) METHYL]THIO}-1H -BENZIMIDAZOLE | 1991 |
|
RU2042673C1 |
METHOD FOR PREPARING METOPROLOL-CONTAINING MICROPARTICLES | 2002 |
|
RU2292878C2 |
METHOD OF PRODUCING PROLONGED-TERM PREPARATION | 0 |
|
SU1326180A3 |
Authors
Dates
1997-02-10—Published
1991-09-10—Filed